Benzinga | Dec 8, 2021 06:54AM EST

TherapeuticsMD Settles US Patent Litigation With Amneal For BIJUVA Allowing For A May 25, 2032 Generic Entry Date

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women's healthcare company, today announced the settlement of the previously disclosed U.S. patent litigation for BIJUVA(r) with Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals, LLC, and Amneal Pharmaceuticals of New York LLC (collectively "Amneal").